An in vitro model for analyzing the nephrotoxicity of cyclosporine and preservation injury

Magnesium deprivation inhibits a MEK-ERK cascade and cell proliferation in renal epithelial Madin-Darby canine kidney cells

AIMS

Loss of magnesium (Mg(2+)) inhibits cell proliferation and augments nephrotoxicant-induced renal injury, but the role of Mg(2+) has not been clarified in detail. We examined the effect of extracellular Mg(2+) deprivation on a MEK-ERK cascade and cell proliferation using a renal epithelial cell line, Madin-Darby canine kidney (MDCK) cells.

MAIN METHODS

MDCK cells were cultured in Mg(2+)-containing or Mg(2+)-free media. A HA-tagged constitutively active (CA)-MEK1 and a dominant negative (DN)-MEK1 were transfected into MDCK cells. The level of protein was examined by Western blotting. The intracellular free Mg(2+) concentration ([Mg(2+)](i)) was measured using a fluorescent dye, mag-fura 2. Cell proliferation was determined by WST-1 assay. Dead cells were identified by staining with annexin V-FITC and propidium iodide.

KEY FINDINGS

In the presence of fetal calf serum (FCS), Mg(2+) deprivation decreased phosphorylated-ERK1/2 (p-ERK1/2) levels and [Mg(2+)](i). Re-addition of Mg(2+) increased p-ERK1/2 levels, which were inhibited by U0126, a specific inhibitor of a MEK-ERK cascade. Glutathione-S-transferase pull-down and coimmunoprecipitation assays showed that CA-MEK1 and DN-MEK1 binds with ERK1/2 in the presence of Mg(2+). In contrast, neither CA-MEK1 nor DN-MEK1 bound to ERK1/2 in the absence of Mg(2+). These results indicate that the MEK-ERK cascade is regulated by [Mg(2+)](i). Cell proliferation was increased by the treatment with FCS or the expression of CA-MEK1 in the presence of Mg(2+), but was inhibited by Mg(2+) deprivation. Mg(2+) deprivation did not increase the number of dead cells.

SIGNIFICANCE

Mg(2+) is involved in the regulation of the MEK-ERK cascade and cell proliferation in MDCK cells.

Cyclosporine A-induced toxicity in two renal cell culture models (LLC-PK1 and MDCK)

Renal damage caused by therapeutic treatment with cyclosporine A has been well documented. Clinical experiences have shown that cyclosporine A nephrotoxicity is determined by interstitial fibrosis with tubular atrophy. However, the exact mechanism by which this drug causes nephrotoxicity has not yet been clarified. This study used an in vitro model in an attempt to identify the cellular mechanisms underlying kidney cyclosporine A damage. We used two cell lines with the characteristics of proximal and distal tubule cells (pig kidney proximal tubular epithelial cell line [LLC-PK1] and Madin-Darby canine kidney cell line [MDCK]. The cell lines were treated with cyclosporine A for 24 h. After the treatment, the cells were stained with Trypan Blue to estimate cell viability and processed by histochemical reactions to evaluate their cellular metabolism. Four enzymes (acid phosphatase, alkaline phosphatase, lactate dehydrogenase and succinate dehydrogenase) were considered. The cell viability assay showed that the LLC-PK1 cell line was more sensitive to cyclosporine A than MDCK. Remarkably, the LLC-PK1 cells disappeared with cyclosporine A treatment. As for the hydrolytic enzymes, only acid phosphatases showed an increased positivity in the treated LLC-PK1 cells. Similarly, lactate dehydrogenase showed a different activity histochemically. No statistically significant alterations were observed in the succinate dehydrogenase reaction. The cyclosporine A-treated MDCK cell lines did not show any difference in either their hydrolytic or succinate dehydrogenase enzyme positivity with respect to the control line. In contrast, there was a significant increase in lactate dehydrogenase activity. This study allowed the possible mechanism of cyclosporine A-induced damage in renal tubular cells to be evaluated. The enzymatic changes happened rapidly (during the 24 h of treatment), suggesting that this alteration was one of the steps by which cyclosporine A induced toxicity. Moreover, since acid phosphatase is a marker of protein catabolism, the variation in the activity of this enzyme, in the LLC-PK1 line only, showed that cyclosporine can induce alterations leading to cellular toxicity. The modifications in lactate dehydrogenase activity, in both lines, suggested that this drug caused cell stress, inducing the production of lactic acid from glucose in the presence of oxygen. In conclusion, cyclosporine A treatment may force LLC-PK1 and MDCK cells to use anaerobic glycolysis preferentially. Further, these enzyme alterations may represent an epiphenomenon or a consequence of cyclosporine A toxicity.

Effect of oxypurinol on cyclosporine toxicity in cultured EA, LLC-PK1 and MDCK cells

It has been proposed that cyclosporin (CsA) toxicity may in part be due to the action of oxygen-based free radicals. We compared the response of cultured endothelial (EA) and epithelial (LLC-PK1 and MDCK) cells to CsA, 250 or 1000 ng/mL for 24 or 72 h, with or without the xanthine oxidase inhibitor oxypurinol (Oxy), 10 mg/mL. CsA-induced alterations were seen on phase contrast and electron microscopy. In EA cells, swollen mitochondria and large cytoplasmic vacuoles surrounded by a thin membrane containing ribosomes were present at the periphery of the cell. In LLC-PK1 cells no vacuoles were present while in MDCK cells, the vacuoles were smaller and more centrally located. In both epithelial cell lines, mitochondria were distorted with loss of cristae. In all three cell lines, CsA depressed cell counts and decreased 3H-thymidine incorporation. Also, LDH release was accelerated. The addition of Oxy minimized the morphologic effect of CsA on all three cell lines with the effect more apparent in EA cells. The CsA-induced reduction of cell replication and increase in LDH release were also attenuated by Oxy. These results support the notion that the peroxidative properties of CsA may be responsible in part for CsA-induced nephrotoxicity.

Brain nuclear DNA survives cardiac arrest and reperfusion

Iron-mediated peroxidation of brain lipids is known to occur during reperfusion following cardiac arrest. Since in vitro damage to DNA is caused by similar iron-dependent peroxidation, we tested whether free radical damage to genomic DNA also develops during reperfusion following cardiac arrest and resuscitation. Genomic DNA was isolated from the cerebral cortex in (i) normal dogs, (ii) dogs subjected to a 20-min cardiac arrest, and (iii) dogs resuscitated from a 20-min cardiac arrest and then allowed to reperfuse for 2 or 8 h. DNA strand nicks were evaluated by in vitro labeling of newly created 3' and 5' termini. DNA base damage was evaluated utilizing reaction with piperidine prior to labeling of 5' termini. The 3' DNA termini were labeled before and after digestion with exonuclease III, and the 5' DNA termini were labeled before and after treatment with piperidine. In vitro experiments with genomic DNA damaged by oxygen radicals verified that these labeling methods identified radical damage. In the experimental animal groups, terminal incorporation and electrophoretic mobility of brain nuclear DNA are not significantly changed either by 20 min of complete brain ischemia or during the first 8 h of reperfusion. We conclude that genomic DNA is not extensively damaged during cardiac arrest and early reperfusion, and therefore such DNA damage does not appear to be an important early aspect of the neurologic injury that accompanies cardiac arrest and resuscitation.